QED International Associates Announces Changes to the HealthShares(TM) Composite, and the HealthShares(TM) Diagnostics Indexes
Companies included in the HealthShares(TM) Diagnostics Index engage inidentification of the existence and extent of a disease, the visuallocalization of a disease by way of imaging, the selection of therapeuticagents appropriate for the disease wherever possible and the monitoring ofdisease progression/therapeutic efficacy.
XShares Advisors LLC, a financial services company based in New York, isthe creator of the HealthShares(TM) family of Exchange Traded Funds (ETFs).HealthShares(TM) ETFs are organized into therapeutic 'Verticals' and representspecific areas of the healthcare, life science and biotechnology industries.Each Vertical addresses a distinct sub-segment of healthcare, such as thediagnosis and treatment of specific therapeutic areas (e.g. cardiology,cancer, infectious disease, etc.) and the development of medical devices (e.g.orthopedic repair, cardio devices, etc.). Each ETF tracks an index of 22-25stocks and offers institutional and individual investors a more precisefinancial instrument that leverages the potential of healthcare investingwhile mitigating the risks of single stock picking. For more information,visit the company's website at: www.healthsharesinc.com.
About QED International Associates
QED International, based in New York, is a leading financial industryconsulting firm specializing in quantitative modeling and the design,development and maintenance of indexes and Exchange Traded Funds. For moreinformation, visit the company's website at www.qedinternational.comContact Information For QED International: Ed Matluck, CEO Michael Carty, Senior Advisor Senior Vice President (212) 953-4058 email@example.com
SOURCE QED International Associates Inc.
You May Also Like